Stock data
Yarrow Bioscience, Inc. (YARW)
Yarrow Bioscience, Inc. (YARW) reported revenue of US$0.57M and net income of -US$26.48M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$0.57M | — | -US$29.75M | -US$26.48M | — |
| 2024 | US$0.50M | — | -US$43.64M | -US$39.83M | — |
| 2023 | US$0.42M | — | -US$29.26M | -US$28.45M | — |
| 2022 | US$0.48M | — | -US$34.30M | -US$23.21M | — |
| 2021 | US$0.93M | — | -US$38.91M | -US$73.33M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | US$0.10M | -US$3.01M | — |
| 2026-03-31 | US$0.09M | -US$3.58M | — |
| 2025-06-30 | US$0.07M | -US$5.75M | — |
| 2025-03-31 | US$0.20M | -US$8.61M | — |
| 2024-12-31 | US$0.08M | -US$12.02M | — |
| 2024-09-30 | US$0.12M | -US$12.16M | — |
| 2024-06-30 | US$0.20M | -US$9.41M | — |
| 2024-03-31 | US$0.10M | -US$6.25M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.